Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
Moderna and other groups get $60 million to develop Ebola vaccineCEPI is investing around $60 million to speed up the creation of vaccines against the deadly Ebola Bundibugyo virus. This funding will supp...
What to know about the Bundibugyo virus, a species of Ebola causing an outbreak in CongoA rare Bundibugyo virus outbreak in Congo, with over 200 deaths, lacks specific treatments or vaccines, complicating response efforts. Whil...
India's semiconductor push gets major boost with $3.3 bn Odisha deal with Intel & 3D Glass SolutionsOdisha, Intel and 3D Glass Solutions Inc. signed an agreement for a new advanced packaging glass core substrate manufacturing facility. Thi...
Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
Ebola outbreak sparks concern in India, US: Should you be worried? Here's what you need to know about signs, symptoms and preventionEbola in India: The WHO has declared the Ebola outbreak in Congo and Uganda a public health emergency with over 300 cases and 88 deaths. In...
Tata Electronics, ASML join hands for semiconductor manufacturing in IndiaTata Electronics and ASML are joining forces to establish chip manufacturing in India. This partnership will support Tata Electronics' new ...
Sun Pharma shares rally 9% in two days after $12-bn Organon deal. Here's what Morgan Stanley, other brokerages saySun Pharmaceutical Industries' shares surged nearly 9% after announcing the $11.75 billion acquisition of Organon & Co., a global leader in...
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
US drugmaker Merck to boost workforce in India, executive saysMerck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employe...
Merck names Dhananjay Singh as MD of Life Science business in IndiaIn his role as MD, Dhananjay Singh will be responsible for driving the life science strategy in India, ensuring governance and compliance a...
Dhananjay Singh takes over as Merck Life Science India MDIn his role as the managing director, Singh will be responsible for driving the life science strategy in India, ensuring governance and com...
Merck India Charitable Trust Scholarship program launched in BengaluruNitin Singh, country speaker, Merck India said that access to education is a priority intervention area for the company in India.
Merck appoints Milind Thatte as MDHe heads the leadership team of healthcare sector and is the member of the country council of Merck India, it added.
German Pharma firm Merck to shut down Bangalore GeNeiMerck KGaA has decided to close down Bangalore GeNei, a company it had acquired in 2009 to bolster capabilities in design and production of...
- Merck and Company firms up plan for emerging markets
Merck has set itself an ambitious target to grow by 25% by 2013 in the emerging markets, or EMs, from 18% now.